LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is scheduled to present at the 2008 Maxim Group Growth Conference on Tuesday, October 7, 2008. Elkan Gamzu, Ph.D., interim chief executive officer of EPIX, is scheduled to discuss the company’s business strategy and corporate overview at 3:00 p.m. (ET) at the Grand Hyatt Hotel in New York City.
